HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

Juan Berenguer,Jose Luis Calleja,María Luisa Montes,Angela Gil,Ana Moreno,Rafael Bañares,Teresa Aldámiz-Echevarría,Agustín Albillos,María J. Téllez,A. Olveira,Lourdes Dominguez-Dominguez,Inmaculada Fernández,Javier García-Samaniego,Benjamín A Polo,Beatriz Álvarez,Pablo Ryan,J. Barrio,M. J. Devesa,Laura Benítez,Ignacio Santos,Luisa García-Buey,Jose M. Sanz,Elvira Poves,Juan Emilio Losa,Conrado M. Fernández-Rodríguez,Inmaculada Jarrin,Maria J Calvo,Juan González-García

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

2019

This work was supported by the Spanish AIDS Research Network (RD16/0025/0017), which is included in the Spanish I+D+I Plan and is co-financed by ISCIII-Subdireccion General de Evaluacion and European Funding for Regional Development (FEDER), and the Fondo de Investigacion de Sanidad en Espana (FIS)/Instituto de Salud Carlos III (Spanish Health Research Funds; PI17/00657).

Keywords:

Virology
HIV Coinfection
Genotype
LEDIPASVIR/SOFOSBUVIR
Medicine
Sofosbuvir
Coinfection
therapy naive
Internal medicine
HIV/AIDS
Hepatitis C
Ledipasvir

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations